26 September 2022 · All calcium channel blockers may cause peripheral oedema. There are different treatment options and the incidence can be affected by different factors.
11 August 2022 · Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration